D Riethmuller1, R Ramanah, J-L Pretet
1Service de Gynécologie Obstétrique, CHU Saint-Jacques, Besançon, France. didier.riethmuller@ufc-chu.univ-fcomte.fr
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Cervical cancer screening in France is suboptimal. Integrating high-risk human papillomavirus (HR HPV) testing, alongside vaccination, can improve detection and population coverage for better cancer prevention.
Area of Science:
Context:
Purpose:
Summary:
Impact: